Century Therapeutics, Inc. (IPSC)

NASDAQ: IPSC · Real-Time Price · USD

0.5260

+0.0013 (0.25%)

At close: May 13, 2025, 4:00 PM

0.5300

+0.0040 (0.76%)

Pre-market: May 14, 2025, 4:22 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Allogeneic Cell Therapies	2.24M	Log In
Allogeneic Cell Therapies Growth	-57.01%	Log In

Revenue by Geography

Fiscal year is January - December.